Process View
Any process that modulates the frequency, rate or extent of vascular endothelial growth factor receptor signaling pathway activity.

In addition to gene-name show these genes:
Click on a gene's description to view its network relationships with genes known to be involved in "regulation of vascular endothelial growth factor receptor signaling pathway"
| Name | Description | Probability | Func Analog Organism | |
|---|---|---|---|---|
| PDGFRA | platelet-derived growth factor receptor, alpha polypeptide | 1.000 | Human | |
| VEGFA | vascular endothelial growth factor A | 1.000 | ||
| PDGFRB | platelet-derived growth factor receptor, beta polypeptide | 0.998 | Human | |
| KDR | kinase insert domain receptor (a type III receptor tyrosine kinase) | 0.997 | Human | |
| NRP1 | neuropilin 1 | 0.986 | Zebrafish | |
| PLCG1 | phospholipase C, gamma 1 | 0.956 | ||
| EGFR | epidermal growth factor receptor | 0.915 | ||
| PDGFB | platelet-derived growth factor beta polypeptide (simian sarcoma viral (v-sis) oncogene homolog) | 0.826 | Human | |
| TGFBR2 | transforming growth factor, beta receptor II (70/80kDa) | 0.753 | ||
| PIK3R1 | phosphoinositide-3-kinase, regulatory subunit 1 (alpha) | 0.732 | ||
| CAV1 | caveolin 1, caveolae protein, 22kDa | 0.519 | ||
| PTPRB | protein tyrosine phosphatase, receptor type, B | 0.428 | ||
| FGFR1 | fibroblast growth factor receptor 1 | 0.399 | ||
| FYN | FYN oncogene related to SRC, FGR, YES | 0.352 | ||
| PDCD6IP | programmed cell death 6 interacting protein | 0.313 | ||
| INSR | insulin receptor | 0.304 | ||
| GRB2 | growth factor receptor-bound protein 2 | 0.207 | ||
| FLT1 | fms-related tyrosine kinase 1 (vascular endothelial growth factor/vascular permeability factor receptor) | 0.193 | ||
| IRS1 | insulin receptor substrate 1 | 0.193 | ||
| CBL | Cas-Br-M (murine) ecotropic retroviral transforming sequence | 0.186 | ||
| ERBB2 | v-erb-b2 erythroblastic leukemia viral oncogene homolog 2, neuro/glioblastoma derived oncogene homolog (avian) | 0.182 | ||
| SHC1 | SHC (Src homology 2 domain containing) transforming protein 1 | 0.158 | ||
| CRK | v-crk sarcoma virus CT10 oncogene homolog (avian) | 0.150 | ||
| LAT | linker for activation of T cells | 0.149 | ||
| PTEN | phosphatase and tensin homolog | 0.141 | ||
| CRKL | v-crk sarcoma virus CT10 oncogene homolog (avian)-like | 0.133 | ||
| LY6G6F | lymphocyte antigen 6 complex, locus G6F | 0.099 | ||
| PAG1 | phosphoprotein associated with glycosphingolipid microdomains 1 | 0.097 | ||
| PTPRJ | protein tyrosine phosphatase, receptor type, J | 0.095 | ||
| ERBB3 | v-erb-b2 erythroblastic leukemia viral oncogene homolog 3 (avian) | 0.093 | ||
| PDGFA | platelet-derived growth factor alpha polypeptide | 0.093 | Human | |
| PDGFC | platelet derived growth factor C | 0.089 | ||
| EPHB1 | EPH receptor B1 | 0.079 | ||
| HDAC7 | histone deacetylase 7 | 0.076 | ||
| TMSB4X | thymosin beta 4, X-linked | 0.068 | ||
| CDH5 | cadherin 5, type 2 (vascular endothelium) | 0.064 | ||
| TTR | transthyretin | 0.062 | ||
| KITLG | KIT ligand | 0.060 | ||
| MAP3K5 | mitogen-activated protein kinase kinase kinase 5 | 0.055 | ||
| IGF1R | insulin-like growth factor 1 receptor | 0.048 | ||
| FAS | Fas (TNF receptor superfamily, member 6) | 0.046 | ||
| PTPN11 | protein tyrosine phosphatase, non-receptor type 11 | 0.045 | ||
| DAPK1 | death-associated protein kinase 1 | 0.037 | ||
| BCAR1 | breast cancer anti-estrogen resistance 1 | 0.034 | ||
| PTK2B | PTK2B protein tyrosine kinase 2 beta | 0.032 | ||
| CYBA | cytochrome b-245, alpha polypeptide | 0.029 | ||
| SOS1 | son of sevenless homolog 1 (Drosophila) | 0.028 | ||
| SHC2 | SHC (Src homology 2 domain containing) transforming protein 2 | 0.027 | ||
| FLT4 | fms-related tyrosine kinase 4 | 0.026 | Human | |
| GRB10 | growth factor receptor-bound protein 10 | 0.026 | ||
| MMP14 | matrix metallopeptidase 14 (membrane-inserted) | 0.024 | ||
| CAV2 | caveolin 2 | 0.020 | ||
| PGF | placental growth factor | 0.020 | Human | |
| PRKCD | protein kinase C, delta | 0.019 | ||
| STC1 | stanniocalcin 1 | 0.019 | ||
| NCF1 | neutrophil cytosolic factor 1 | 0.018 | ||
| ASAP1 | ArfGAP with SH3 domain, ankyrin repeat and PH domain 1 | 0.017 | ||
| MET | met proto-oncogene (hepatocyte growth factor receptor) | 0.017 | ||
| PTPN23 | protein tyrosine phosphatase, non-receptor type 23 | 0.016 | ||
| RRBP1 | ribosome binding protein 1 homolog 180kDa (dog) | 0.015 | ||
| SLC9A3R1 | solute carrier family 9 (sodium/hydrogen exchanger), member 3 regulator 1 | 0.015 | ||
| KIT | v-kit Hardy-Zuckerman 4 feline sarcoma viral oncogene homolog | 0.015 | Human | |
| MAPK1IP1L | mitogen-activated protein kinase 1 interacting protein 1-like | 0.014 | ||
| EGLN1 | egl nine homolog 1 (C. elegans) | 0.014 | ||
| IRS2 | insulin receptor substrate 2 | 0.014 | ||
| SMAD5 | SMAD family member 5 | 0.014 | ||
| RXRA | retinoid X receptor, alpha | 0.014 | ||
| NAGK | N-acetylglucosamine kinase | 0.013 | ||
| GAB1 | GRB2-associated binding protein 1 | 0.013 | ||
| BTK | Bruton agammaglobulinemia tyrosine kinase | 0.012 | ||
| NDP | Norrie disease (pseudoglioma) | 0.012 | ||
| SMAD1 | SMAD family member 1 | 0.012 | ||
| ROBO4 | roundabout homolog 4, magic roundabout (Drosophila) | 0.012 | ||
| TGFB3 | transforming growth factor, beta 3 | 0.012 | ||
| TTC19 | tetratricopeptide repeat domain 19 | 0.011 | ||
| EGLN3 | egl nine homolog 3 (C. elegans) | 0.011 | ||
| JAK2 | Janus kinase 2 | 0.011 | ||
| MAP4K1 | mitogen-activated protein kinase kinase kinase kinase 1 | 0.010 | ||
| EPAS1 | endothelial PAS domain protein 1 | 0.010 | ||
| TRIM9 | tripartite motif containing 9 | 0.010 |